# Feline Core Vaccines: FVRCP and Rabies Recommended Protocol


## Key Takeaways

- Core feline vaccines, FVRCP (Feline Viral Rhinotracheitis, Calicivirus, Panleukopenia) and Rabies, are recommended for all cats regardless of lifestyle due to disease prevalence, contagiousness, and zoonotic risk, as per the 2020 AAHA/AAFP Feline Vaccination Guidelines.
- Kittens require an FVRCP series starting at 6-8 weeks of age, with boosters every 3-4 weeks until 16-20 weeks, and a single rabies vaccine at 12-16 weeks; adult cats with unknown history receive one FVRCP and one rabies dose, followed by 1-year boosters, then FVRCP every 3 years.
- FVRCP protects against feline herpesvirus type 1 (FHV-1), feline calicivirus (FCV), and feline panleukopenia virus (FPV), with immunity duration varying by pathogen, potentially waning faster for FHV-1 than FPV and FCV.
- Rabies vaccination is a legal mandate in most North American jurisdictions due to its fatal zoonotic nature and potential for wildlife exposure, necessitating core vaccination even for indoor-only cats.
- Adverse events, though uncommon, include feline injection-site sarcoma (FISS), lethargy, and soreness; minimizing risk involves using non-adjuvanted vaccines, administering them at recommended anatomical sites, and avoiding unnecessary vaccinations.
- Client communication regarding the necessity of core vaccines for indoor cats, the diseases prevented, and potential adverse events is crucial for vaccination compliance, with veterinarians identified as the primary information source for owners.

---

## At a Glance: What Every Cat Owner Needs to Know

Core vaccines are those recommended for every [cat](/knowledge/veterinary-medicine/clinical-methods/cat), regardless of lifestyle, because the diseases they prevent are widespread, highly contagious, or pose a serious zoonotic risk. For cats, the core vaccine panel consists of two components: the FVRCP vaccine (protecting against feline viral rhinotracheitis, calicivirus, and panleukopenia) and the rabies vaccine.

The 2020 AAHA/AAFP Feline Vaccination Guidelines, a consensus report from a task force of experts, assign approved feline vaccines to core and non-core categories [<a href="#ref-1">1</a>]. Core vaccines are recommended for all cats, while non-core vaccines are administered based on an individualized risk-benefit assessment [<a href="#ref-1">1</a>].

This article provides a comprehensive, source-grounded review of the FVRCP and rabies recommended protocol, including vaccination schedules, duration of immunity, risk factors, adverse events, and practical guidance for veterinary professionals and cat owners.

**Owner Triage Summary:**
- Kittens require a series of FVRCP vaccines starting at 6 to 8 weeks of age, given every 3 to 4 weeks until 16 to 20 weeks of age.
- A single rabies vaccine is given at 12 to 16 weeks of age, with boosters according to local law and vaccine label (1-year or 3-year products).
- Adult cats with unknown vaccination history should receive one FVRCP dose and one rabies dose, followed by a booster at 1 year.
- After the initial series and the 1-year booster, FVRCP is given every 3 years. Rabies booster intervals depend on local regulations and product label.
- Indoor-only cats still require core vaccines. The most common owner barrier to vaccination is the belief that indoor cats do not need vaccines [<a href="#ref-2">2</a>].

## Understanding Feline Core Vaccines

### The FVRCP Vaccine

The FVRCP vaccine is a combination product that protects against three pathogens:

1. **Feline viral rhinotracheitis (FVR)** caused by feline herpesvirus type 1 (FHV-1)
2. **[Feline calicivirus](/knowledge/viruses/pet-viruses/feline-calicivirus) (FCV)**
3. **[Feline panleukopenia virus](/knowledge/viruses/pet-viruses/feline-panleukopenia-virus) (FPV)**

These three pathogens are considered core vaccine targets and are widely recommended for feline immunoprophylaxis [<a href="#ref-3">3</a>]. The vaccine is available in modified live and inactivated formulations, with trivalent products being the standard in clinical practice [<a href="#ref-3">3</a>].

**FHV-1** is a major cause of upper respiratory tract disease in cats. Infection is characterized by sneezing, nasal discharge, conjunctivitis, and corneal ulcers. Like other herpesviruses, FHV-1 establishes latency, and reactivation can occur during stress or immunosuppression [<a href="#ref-4">4</a>]. The modified live vaccine strain F2 has been associated with corneal lesions in some cases, particularly in young kittens, but this is uncommon [<a href="#ref-4">4</a>].

**FCV** is a highly contagious, genetically variable virus that causes oral ulceration, upper respiratory signs, and sometimes pneumonia in kittens [<a href="#ref-5">5</a>]. Highly virulent strains can cause severe systemic disease with high mortality [<a href="#ref-5">5</a>]. Vaccination protects against disease but does not prevent infection or shedding [<a href="#ref-5">5</a>].

**FPV** causes panleukopenia, a severe and often fatal disease characterized by profound leukopenia, gastroenteritis, and immunosuppression. FPV is closely related to [canine parvovirus](/knowledge/veterinary-medicine/viral-diseases/canine-parvovirus) type 2 and is extremely stable in the environment.

### The Rabies Vaccine

Rabies is a fatal zoonotic disease caused by lyssaviruses. In North America, rabies vaccination is mandated by law in most jurisdictions. The rabies vaccine is a core vaccine for all cats, including indoor-only cats, because of the public health risk and the potential for escape or exposure to rabid wildlife [<a href="#ref-6">6</a>].

## The Recommended FVRCP and Rabies Protocol

### Kitten Primary Vaccination Series

The primary vaccination series for kittens is designed to overcome interference from maternally derived antibodies (MDA). Kittens receive passive immunity from colostrum, and high levels of MDA can neutralize vaccine antigens, preventing an adequate immune response.

The 2020 AAHA/AAFP guidelines recommend the following schedule for kittens [<a href="#ref-1">1</a>]:

- **First FVRCP dose:** 6 to 8 weeks of age
- **Subsequent FVRCP doses:** every 3 to 4 weeks until 16 to 20 weeks of age
- **Rabies vaccine:** single dose at 12 to 16 weeks of age

The final dose of the kitten series should be given at or after 16 weeks of age to ensure that MDA has waned sufficiently for the kitten's immune system to respond [<a href="#ref-1">1</a>].

### Adult Cat Vaccination

For adult cats with an unknown vaccination history, the guidelines recommend [<a href="#ref-1">1</a>]:

- **One dose of FVRCP** followed by a booster at 1 year
- **One dose of rabies vaccine** followed by a booster at 1 year according to local law

For adult cats with a known vaccination history, the booster intervals are:

- **FVRCP:** every 3 years after the 1-year booster
- **Rabies:** according to local law and product label (1-year or 3-year products)

### Duration of Immunity

The recommendation for 3-year booster intervals for FVRCP is supported by controlled vaccination-challenge studies. In one laboratory trial, cats vaccinated with a non-adjuvanted FVRCP vaccine and boosted at 1 year were challenged with virulent FCV and FHV-1 strains 3 years later [<a href="#ref-7">7</a>]. Vaccination resulted in a significant reduction in disease severity after FHV challenge and a reduction in the frequency of severe calicivirus disease [<a href="#ref-7">7</a>].

A large Italian study of 740 cats (567 owned and 173 stray) evaluated protective antibody titers (PATs) against FPV, FeHV-1, and FCV using the VacciCheck test [<a href="#ref-8">8</a>]. The study found that:

- Less than half of the entire cohort (36.4%) had PATs for all three diseases simultaneously
- When weak positive values were included, this increased to 48.6%
- Among vaccinated cats only, 50.3% had PATs for all three diseases
- Most cats maintained high PATs for 3 years or longer after vaccination against FPV and FCV, but not against FeHV-1 [<a href="#ref-8">8</a>]

This study highlights that while many cats maintain protective titers for extended periods, the duration of immunity varies by pathogen and individual animal. FeHV-1 immunity appears to wane more quickly than FPV and FCV immunity [<a href="#ref-8">8</a>].

## Risk Assessment and Lifestyle Considerations

### Indoor vs. Outdoor Cats

A common owner concern is that indoor cats do not require vaccination because they are not exposed to other animals [<a href="#ref-2">2</a>, <a href="#ref-6">6</a>]. However, the 2020 AAHA/AAFP guidelines recommend core vaccines for all cats regardless of lifestyle [<a href="#ref-1">1</a>].

Indoor cats can still be exposed to pathogens through:
- Escapes or accidental outdoor access
- Introduction of new cats into the household
- Fomite transmission (virus carried on clothing, shoes, or objects)
- Boarding facilities or veterinary visits

The perception that indoor cats do not need vaccines is one of the most common barriers to feline vaccination compliance [<a href="#ref-2">2</a>]. In a global survey of 1,330 veterinarians and 5,071 cat owners across 14 countries, 27% of owners who chose not to vaccinate believed vaccines were unnecessary for healthy or indoor cats [<a href="#ref-2">2</a>].

### Risk Stratification

While core vaccines are recommended for all cats, the 2020 AAHA/AAFP guidelines note that cats can be classified as low- and high-risk based on their lifestyle [<a href="#ref-8">8</a>]. This risk assessment primarily affects the use of non-core vaccines and the frequency of booster administration.

Factors that increase infection risk include:
- Outdoor access
- Multi-cat households
- Boarding or cattery exposure
- Cat shows or other group events
- History of respiratory disease in the household

## Vaccine Compliance and Owner Perceptions

### Global Vaccination Rates

Despite the clear benefits of vaccination, a substantial proportion of cats are not fully vaccinated. A large sentinel network study in Great Britain found that 77.9% of animals had recorded vaccinations, with higher rates in dogs than cats [<a href="#ref-9">9</a>]. Cats received more core vaccines per year of life (0.86) than dogs (0.75), but a significant proportion of cats were not benefiting from vaccine protection [<a href="#ref-9">9</a>].

In the United States, a study of transactional data from 1,914,373 cats across 1,661 practices found that non-core vaccination rates varied widely between practices [<a href="#ref-10">10</a>]. This variability suggests that individual clinician assessment plays a significant role in vaccine recommendations, which can lead to inconsistencies in care [<a href="#ref-10">10</a>].

### Drivers and Barriers to Vaccination

A global survey of cat owners and veterinarians identified several key factors affecting vaccination compliance [<a href="#ref-2">2</a>]:

**Drivers for cat owners:**
- Desire to maintain their cat's health (62%)
- Veterinarian's recommendation (57%)

**Veterinarian-perceived drivers:**
- Vaccine reminders (71%)

**Barriers reported by veterinarians:**
- Lack of client understanding (53%)
- Vaccine misinformation (51%)
- Antivaccine attitudes (51%)

Notably, most cat owners (58%) cited their veterinarian as their primary vaccine information source, yet only 23% of veterinarians report discussing the importance of vaccination with cat owners [<a href="#ref-2">2</a>]. This represents a significant missed opportunity for client education.

### The Impact of the Antivaccine Movement

The human antivaccine movement has begun to affect companion animal vaccination. A survey of 1,341 US veterinarians found that veterinarians reported an increased number of [dog](/knowledge/veterinary-medicine/clinical-methods/dog) and cat owners reluctant about or resistant to rabies and core vaccines since COVID-19 vaccines became widely available [<a href="#ref-6">6</a>]. There was an association between veterinarians' perceptions of local COVID-19 antivaccination sentiments and the increase in vaccine-resistant clients [<a href="#ref-6">6</a>].

Similarly, a survey of American and Canadian veterinarians found a positive correlation between an organized antivaccine movement against mandatory childhood vaccination in their community and the number of vaccine-resistant or concerned clients [<a href="#ref-11">11</a>]. This suggests that the human antivaccine movement is impacting pet owners' views on companion animal vaccinations [<a href="#ref-11">11</a>].

## Adverse Events and Safety Considerations

### Feline Injection-Site Sarcoma

The most significant adverse event associated with feline vaccination is the feline injection-site sarcoma (FISS), formerly known as vaccine-associated sarcoma. This is a malignant tumor that can develop at the site of injection, typically months to years after vaccination.

The 2020 AAHA/AAFP guidelines provide an update on FISS, indicating that the occurrence of this sequela remains infrequent and idiosyncratic [<a href="#ref-1">1</a>]. While the risk is low, it is a primary concern for veterinarians when vaccinating cats [<a href="#ref-6">6</a>, <a href="#ref-11">11</a>].

To minimize the risk of FISS:
- Use non-adjuvanted vaccines when available
- Administer vaccines at recommended anatomical sites (distal limbs for rabies, as recommended by guidelines)
- Avoid unnecessary vaccinations
- Document the vaccine brand, lot number, and injection site for every cat

### Other Adverse Events

Veterinarians report several other concerns when vaccinating cats, including [<a href="#ref-6">6</a>, <a href="#ref-11">11</a>]:
- Lethargy
- Soreness at the injection site
- Anaphylaxis (rare but potentially fatal)

Cat owners prioritize low side effects (88%) when considering vaccination [<a href="#ref-2">2</a>]. Most adverse events are mild and self-limiting, but clients should be advised to monitor their cat for 24 to 48 hours after vaccination and to contact their veterinarian if they observe:
- Persistent lethargy or anorexia
- Facial swelling or hives
- Vomiting or diarrhea
- Difficulty breathing (emergency)

### Modified Live Vaccine Risks

Modified live vaccines (MLV) for FHV-1 can, in rare cases, cause clinical disease. A case report described two 2-month-old kittens that developed sneezing, ocular discharge, and corneal lesions (dendritic ulcers) after vaccination with an FHV-1 MLV strain F2 [<a href="#ref-4">4</a>]. Genomic analysis confirmed that the FHV-1 strains isolated from the kittens were identical to the vaccine strain [<a href="#ref-4">4</a>].

While this complication is rare, it underscores the importance of using vaccines according to label instructions and monitoring young kittens after vaccination.

## Regional Considerations

### North America

In the United States and Canada, rabies vaccination is required by law in most jurisdictions. The 2020 AAHA/AAFP guidelines are the primary reference for feline vaccination protocols in North America [<a href="#ref-1">1</a>]. These guidelines are published simultaneously in the Journal of Feline Medicine and Surgery and the Journal of the American Animal Hospital Association [<a href="#ref-1">1</a>].

The American Veterinary Medical Association (AVMA) and the Canadian Veterinary Medical Association (CVMA) support the AAHA/AAFP guidelines and recommend adherence to core vaccination protocols.

### Europe

In Europe, the European Advisory Board on Cat Diseases (ABCD) provides evidence-based guidelines for feline infectious diseases and vaccination. The ABCD recommends that all cats be vaccinated against FCV as a core vaccine [<a href="#ref-5">5</a>]. The ABCD also emphasizes that vaccination protects against disease but not infection, and that changing to different vaccine strains may be beneficial if disease occurs in fully vaccinated cats [<a href="#ref-5">5</a>].

The Federation of Veterinarians of Europe (FVE) supports core vaccination for all cats, with rabies vaccination recommended based on regional risk and travel requirements.

### Australia and New Zealand

Australia is rabies-free, and rabies vaccination is not routinely required for cats unless they are being exported. However, core vaccination with FVRCP is recommended for all cats. A survey of New Zealand veterinary practices found that 59.1% of respondents recommended annual administration of modified live vaccines to cats [<a href="#ref-12">12</a>]. This is higher than the 3-year interval recommended by the AAHA/AAFP guidelines, suggesting that some practices have not fully adopted extended booster intervals [<a href="#ref-12">12</a>].

The Australian Veterinary Association (AVA) recommends core vaccination for all cats, with protocols similar to those in North America and Europe.

## The Role of Antibody Titer Testing

Antibody titer testing can be used to assess a cat's immune status against core vaccine antigens. The VacciCheck test is a semiquantitative in-clinic test that measures antibodies against FPV, FeHV-1, and FCV [<a href="#ref-8">8</a>].

While titer testing can be useful for:
- Assessing immunity in cats with unknown vaccination history
- Evaluating immune status in cats with a history of adverse vaccine reactions
- Determining whether a booster is needed in older cats

The 2020 AAHA/AAFP guidelines do not recommend routine titer testing in place of vaccination [<a href="#ref-1">1</a>]. Titer results do not always correlate with protection, particularly for FeHV-1 and FCV, where cell-mediated immunity plays a significant role [<a href="#ref-8">8</a>].

## Practical Implementation in Veterinary Practice

### Client Communication

Effective client communication is essential for vaccination compliance. The 2020 AAHA/AAFP guidelines emphasize that staff education initiatives should enable the veterinary practice team to be proficient in advising clients on proper vaccination practices and compliance [<a href="#ref-1">1</a>].

Key communication points include:
- Explain why core vaccines are recommended for all cats, including indoor cats
- Discuss the diseases prevented and their severity
- Address owner concerns about adverse events, including FISS
- Provide written information about vaccination schedules
- Use vaccine reminders to improve compliance [<a href="#ref-2">2</a>]

### The Vaccination Visit

The vaccination visit should always include [<a href="#ref-1">1</a>]:
- A thorough physical examination
- Client education dialog about disease risk assessment
- Discussion of the proposed vaccination protocol
- Documentation of vaccine administration (brand, lot number, site)

Vaccination is a component of a preventive healthcare plan, not a standalone procedure [<a href="#ref-1">1</a>].

### Documentation and Record Keeping

Accurate documentation is critical for:
- Tracking vaccination status
- Managing adverse events
- Meeting legal requirements for rabies vaccination
- Facilitating titer testing and booster decisions

For every vaccine administered, record:
- Date of administration
- Vaccine brand and product name
- Lot number and expiration date
- Injection site
- Route of administration

## Emerging Vaccine Technologies

### FHV-1 as a Vaccine Vector

Feline herpesvirus type 1 has demonstrated notable potential as a viral vector for multivalent vaccine development [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>]. Its large genome and immunogenic profile make it an attractive platform for expressing antigens from other feline pathogens [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>].

A recent study developed a novel trivalent live attenuated vaccine candidate by engineering FHV-1 to co-express immunogenic proteins from FPV and FCV [<a href="#ref-3">3</a>]. The recombinant virus was genetically stable during in vitro passaging and induced robust virus-neutralizing antibody responses in vaccinated cats [<a href="#ref-3">3</a>].

This approach could lead to next-generation feline vaccines that provide broader protection with fewer injections [<a href="#ref-3">3</a>, <a href="#ref-13">13</a>].

### Virus-Like Particle Vaccines

Domestic cat hepadnavirus (DCHBV) core antigen has been shown to self-assemble into virus-like particles (VLPs) [<a href="#ref-14">14</a>]. These VLPs offer a novel scaffold for chimeric vaccine development and epitope display [<a href="#ref-14">14</a>]. Due to the phylogenetic distance from human hepatitis B virus, DCHBVcAg-based VLPs are unlikely to be affected by pre-existing immunity in non-feline species [<a href="#ref-14">14</a>].

While this research is in early stages, it represents a promising avenue for feline vaccine development.

## Limitations and When to Contact a Veterinarian

This article provides general information about feline core vaccines, but it cannot predict individual patient responses or account for specific medical conditions. Breed-level information cannot predict how a particular cat will respond to vaccination.

Contact your veterinarian if your cat:
- Has a history of adverse vaccine reactions
- Is immunocompromised (e.g., FIV or FeLV positive, on immunosuppressive medications)
- Is pregnant or nursing
- Has a chronic illness
- Is due for vaccinations and you have questions about the protocol

Emergency red flags after vaccination include:
- Facial swelling or hives
- Difficulty breathing
- Collapse or loss of consciousness
- Persistent vomiting or diarrhea
- Seizures

These signs may indicate anaphylaxis or a severe adverse reaction and require immediate veterinary attention.

## Frequently Asked Questions

### 1. What does FVRCP stand for?
FVRCP stands for Feline Viral Rhinotracheitis, Calicivirus, and Panleukopenia. It is a combination vaccine that protects against three core feline pathogens: feline herpesvirus type 1 (FVR), feline calicivirus (FCV), and [feline panleukopenia](/knowledge/veterinary-medicine/viral-diseases/feline-panleukopenia) virus (FPV) [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>].

### 2. How often does my cat need the FVRCP vaccine?
After the initial kitten series and a booster at 1 year, the FVRCP vaccine is recommended every 3 years [<a href="#ref-1">1</a>]. This recommendation is supported by duration of immunity studies showing protection for at least 3 years after vaccination [<a href="#ref-7">7</a>].

### 3. Does my indoor cat really need vaccines?
Yes. The 2020 AAHA/AAFP guidelines recommend core vaccines for all cats regardless of lifestyle [<a href="#ref-1">1</a>]. Indoor cats can be exposed to pathogens through escapes, new cats entering the household, or fomite transmission on clothing and objects.

### 4. What is the difference between a 1-year and 3-year rabies vaccine?
The difference is the labeled duration of immunity. A 1-year rabies vaccine provides protection for 1 year, while a 3-year rabies vaccine provides protection for 3 years. The choice depends on local law and the specific product used. Both are considered core vaccines for cats [<a href="#ref-1">1</a>].

### 5. Can my cat have a vaccine reaction?
Yes, adverse reactions can occur, though they are uncommon. The most common concerns for veterinarians include vaccine-associated sarcoma, lethargy, and soreness at the injection site [<a href="#ref-6">6</a>, <a href="#ref-11">11</a>]. Most reactions are mild and self-limiting, but severe reactions such as anaphylaxis, while rare, require immediate veterinary care.

### 6. What is a feline injection-site sarcoma?
Feline injection-site sarcoma (FISS) is a malignant tumor that can develop at the site of vaccination, typically months to years later. The occurrence remains infrequent and idiosyncratic [<a href="#ref-1">1</a>]. Using non-adjuvanted vaccines and administering vaccines at recommended sites can help minimize the risk.

### 7. Can I use antibody titer testing instead of vaccinating my cat?
Titer testing can assess antibody levels against core vaccine antigens, but the 2020 AAHA/AAFP guidelines do not recommend routine titer testing in place of vaccination [<a href="#ref-1">1</a>]. Titer results do not always correlate with protection, particularly for FHV-1 and FCV [<a href="#ref-8">8</a>].

### 8. Why does my veterinarian recommend different vaccines for my cat than for my neighbor's cat?
Vaccination protocols should be individualized based on the cat's life stage, lifestyle, and risk of exposure [<a href="#ref-1">1</a>]. Core vaccines are recommended for all cats, but non-core vaccines are administered based on an individualized risk-benefit assessment [<a href="#ref-1">1</a>]. Your veterinarian considers your cat's specific circumstances when making recommendations.

<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "FAQPage",
  "mainEntity": [
    {
      "@type": "Question",
      "name": "What does FVRCP stand for?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "FVRCP stands for Feline Viral Rhinotracheitis, Calicivirus, and Panleukopenia. It is a combination vaccine that protects against three core feline pathogens: feline herpesvirus type 1 (FVR), feline calicivirus (FCV), and feline panleukopenia virus (FPV)."
      }
    },
    {
      "@type": "Question",
      "name": "How often does my cat need the FVRCP vaccine?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "After the initial kitten series and a booster at 1 year, the FVRCP vaccine is recommended every 3 years. This recommendation is supported by duration of immunity studies showing protection for at least 3 years after vaccination."
      }
    },
    {
      "@type": "Question",
      "name": "Does my indoor cat really need vaccines?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes. The 2020 AAHA/AAFP guidelines recommend core vaccines for all cats regardless of lifestyle. Indoor cats can be exposed to pathogens through escapes, new cats entering the household, or fomite transmission on clothing and objects."
      }
    },
    {
      "@type": "Question",
      "name": "What is the difference between a 1-year and 3-year rabies vaccine?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "The difference is the labeled duration of immunity. A 1-year rabies vaccine provides protection for 1 year, while a 3-year rabies vaccine provides protection for 3 years. The choice depends on local law and the specific product used. Both are considered core vaccines for cats."
      }
    },
    {
      "@type": "Question",
      "name": "Can my cat have a vaccine reaction?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Yes, adverse reactions can occur, though they are uncommon. The most common concerns for veterinarians include vaccine-associated sarcoma, lethargy, and soreness at the injection site. Most reactions are mild and self-limiting, but severe reactions such as anaphylaxis, while rare, require immediate veterinary care."
      }
    },
    {
      "@type": "Question",
      "name": "What is a feline injection-site sarcoma?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Feline injection-site sarcoma (FISS) is a malignant tumor that can develop at the site of vaccination, typically months to years later. The occurrence remains infrequent and idiosyncratic. Using non-adjuvanted vaccines and administering vaccines at recommended sites can help minimize the risk."
      }
    },
    {
      "@type": "Question",
      "name": "Can I use antibody titer testing instead of vaccinating my cat?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Titer testing can assess antibody levels against core vaccine antigens, but the 2020 AAHA/AAFP guidelines do not recommend routine titer testing in place of vaccination. Titer results do not always correlate with protection, particularly for FHV-1 and FCV."
      }
    },
    {
      "@type": "Question",
      "name": "Why does my veterinarian recommend different vaccines for my cat than for my neighbor's cat?",
      "acceptedAnswer": {
        "@type": "Answer",
        "text": "Vaccination protocols should be individualized based on the cat's life stage, lifestyle, and risk of exposure. Core vaccines are recommended for all cats, but non-core vaccines are administered based on an individualized risk-benefit assessment. Your veterinarian considers your cat's specific circumstances when making recommendations."
      }
    }
  ]
}
</script>

---

## Related Clinical & Scientific Guides

* [Dog Allergic Reaction: Comprehensive Veterinary Reference Guide](/knowledge/veterinary-medicine/preventive-care/dog-allergic-reaction)
* [Puppy Socialization and Preventive Behavior: Early Training and Handling](/knowledge/veterinary-medicine/preventive-care/puppy-socialization-preventive-behavior)
* [Dog Boarding 101: How to Choose the Best Facility for Your Pet](/knowledge/veterinary-medicine/preventive-care/dog-boarding-guide)